← Eichor
Study identifier: NCT06716242 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Validation of the MaiRa Preeclampsia Test for Screening Early/Late Preeclampsia in First and Second Trimesters

Condition: Preeclampsia (PE)  ·  Sponsor: iPremom

PhaseN/A
Planned participants7473
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Preeclampsia (PE) is a major obstetric complication with severe short- and long-term consequences for both mother and fetus. Early detection is critical to mitigate PE-related morbidity and mortality. Effective screening tools are needed to identify women at risk, enabling timely preventive and therapeutic interventions. Current screening methods primarily target placental biomarkers like sFLT1 and PlGF, which are limited to short-term predictions near symptom onset. Existing first-trimester assessments that incorporate maternal factors and Doppler metrics remain constrained by low sensitivity (\<41%) in compliance with NICE and ACOG guidelines. Recent advancements in cell free RNA (cf-RNA) analysis have revealed potential in first-trimester PE prediction. Findings from the PREMOM study (NCT04990141) established a molecular profile for early-onset preeclampsia (EOPE) and late-onset preeclampsia (LOPE) through cfRNA analysis, culminating in the development of the MaiRa Preeclampsia Test (Maternal Advanced and Innovative Preeclampsia Risk Assessment), which demonstrated high predictive performance for first- and second-trimester screening. The current study hypothesizes that the MaiRa Preeclampsia Test is generalizable, maintaining its predictive accuracy in an independent cohort.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Studies Department  ·  +34 636 260 481  ·  clinicalstudies@ipremom.com

Érika Ortiz Domingo  ·  +34 636 260 481  ·  erika.ortiz@mshareservices.es

Always discuss trial participation with your own doctor first.

Locations (11)

Hospital General Universitario Dr. BalmisAlicante, Alicante, SpainRecruiting
Hospital de la Santa Creu i Sant PauBarcelona, Barcelona, SpainRecruiting
Hospital Comarcal de VinaròsVinaròs, Castellón, SpainRecruiting
Hospital Universitario Puerta del MarCadiz, Cádiz, SpainRecruiting
Hospital Universitario A CoruñaA Coruña, La Coruña, SpainRecruiting
Hospital Universitario de TorrejónTorrejón de Ardoz, Madrid, SpainRecruiting
Hospital Clínico Universitario Virgen de la ArrixacaEl Palmar, Murcia, SpainRecruiting
Hospital Universitario de CanariasSan Cristóbal de La Laguna, Santa Cruz de Tenerife, SpainRecruiting
Hospital de ManisesManises, Valencia, SpainRecruiting
Hospital Universitario Doctor PesetValencia, Valencia, SpainRecruiting
Hospital Universitario y Politécnico La FeValencia, Valencia, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06716242